OncoQuest Pharmaceuticals Inc Cash Flow Quality Index
OncoQuest Pharmaceuticals Inc cash flow quality index. OncoQuest Pharmaceuticals Inc (078590) has a Cash Flow Quality Index of -0.21x as of June 2025. Operating cash flow of ₩-303.65 Million is below net income of ₩1.46 Billion, suggesting accrual-heavy earnings not yet converted to cash. See OncoQuest Pharmaceuticals Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of OncoQuest Pharmaceuticals Inc (2014–2024)
Cash flow quality index of OncoQuest Pharmaceuticals Inc from 2014 to 2024. Historical Cash Flow Quality Index for OncoQuest Pharmaceuticals Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore OncoQuest Pharmaceuticals Inc (078590) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
OncoQuest Pharmaceuticals Inc Cash Flow Quality Index by Year (2014–2024)
OncoQuest Pharmaceuticals Inc cash flow quality index by year from 2014 to 2024. Year-by-year earnings quality comparison for OncoQuest Pharmaceuticals Inc. For the full cash flow conversion analysis, see OncoQuest Pharmaceuticals Inc operating cash flow efficiency.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.86x | ₩3.96 Billion | ₩4.60 Billion | ▼ -36.8% |
| 2023 | 1.36x | ₩11.19 Billion | ₩8.20 Billion | ▲ +5704.1% |
| 2022 | -0.02x | ₩-236.91 Million | ₩9.73 Billion | ▼ -101.3% |
| 2017 | 1.84x | ₩4.79 Billion | ₩2.60 Billion | ▲ +29.9% |
| 2016 | 1.42x | ₩3.54 Billion | ₩2.49 Billion | ▼ -32.9% |
| 2015 | 2.12x | ₩2.79 Billion | ₩1.32 Billion | ▲ +40.9% |
| 2014 | 1.50x | ₩1.02 Billion | ₩675.61 Million | — |